THE DRM LAB — Ad Rulebook Rev. 2
PDRN Micro-Infusion Treatment System. 205 rules across 7 categories, merged from the Ad Bounty Brief (Creator Rules v1.5), the QA Rules full text v1.6, and the program ruling on price and offer framing. Hardest tier first inside every sub-category.
Quick-Look Rule Index
| Category | T1 Prohibited | T2 Required | T3 Conditional | T4 Preferred | T5 Optional | Total |
|---|---|---|---|---|---|---|
| 1. Claim Rules | 18 | 8 | 8 | 3 | 14 | 51 |
| 2. Copy/Messaging Rules | 13 | 6 | 9 | 24 | 12 | 64 |
| 3. AI Use Rules | 6 | 0 | 3 | 1 | 1 | 11 |
| 4. Visual Rules | 12 | 6 | 3 | 10 | 6 | 37 |
| 5. Competitor Rules | 4 | 0 | 4 | 4 | 0 | 12 |
| 6. Ad Formats Disallowed | 2 | 1 | 2 | 3 | 0 | 8 |
| 7. Audience & Targeting Rules | 3 | 4 | 3 | 11 | 1 | 22 |
| Total primary rules | 58 | 25 | 32 | 56 | 34 | 205 |
Gate Reference
| Gate | Meaning | Rules |
|---|---|---|
| HARD LINE | Brand QA automatic fail. If present, fail — no judgement. v1.6 §1b. | 21 |
| CANNOT | Brand QA prohibition, but not auto-fail. A reviewer must judge it. | 88 |
| GUIDANCE | Direction only. v1.6: do not flag. | 63 |
| TECH | Technical QA — runs before brand QA. Absent from v1.6. | 3 |
| PROGRAM | Program launch block. Governs whether it runs, not whether QA passes. | 20 |
| — | No gate stated in any source | 10 |
Sources & Precedence
Submission Requirements
1. Claim Rules
What the ad may and may not assert. Product truth is not advertising permission: a statement can be accurate about the product and still be a claim the brief prohibits. This category carries the densest concentration of automatic fails — 10 of the 11 v1.6 hard lines land here or on a claim-carrying rule.
1.1 Prohibited Product Outcome & Transformation Claims
Never state cures, heals, erases, removes, gone, permanent or 100% fixes as a product claim.
Wording · Literal product claims: ‘cures’, ‘heals’, ‘erases’, ‘100% fixes’ your scars. · “Removes”, “erases”, “cures”, “permanent results”.
Scope · Brand copy, voiceover, on-screen text, hook, end card
Notes · v1.6 hard line 1 and the ALWAYS FAIL list. Fails wherever it appears, hook included. Note that ‘removes’, ‘gone’ and ‘permanent’ appear in the B1 and ALWAYS FAIL lists but not in the v1.6 hard-line pattern list — see CF-07.
Never promise a timeline for results.
Wording · Promise a timeline to the viewer (‘results in 1 month’, ‘I promise you will see results’). The only promise the brand makes is the 90-day money-back guarantee.
Scope · All copy, all formats
Example · On-screen “RESULTS IN 1 MONTH” plus “I promise you will see results” → two timeline promises, both cut
Notes · v1.6 hard line 2. Naming the 90-day guarantee window is permitted; promising results by that date is not. A real person reporting their own timeline is not a promise — UGC-14.
Never state guaranteed skin outcomes, “will work”, or “results you can count on”.
Wording · Guarantee a skin outcome or use phrases like ‘will work’ or implied-certainty phrasing like ‘results you can count on”.
Notes · v1.6 ALWAYS FAIL.
Never state a clean, round or absolute percentage as a product claim.
Wording · A clean, round or absolute percentage as a product claim (“50% reduction”, “100% improvement”).
Scope · Product claims only — a real person’s own hedged estimate is not a product claim
Notes · v1.6 names the mechanism: “The hedge and the fact it is that person’s own estimate are what make it honest; a clean round number stated as what the product does is what fails.” See CLM-30.
1.2 Prohibited Regulatory, Credential & Facility Claims
Never say “FDA approved” in any form.
Wording · Claim ‘FDA approved’ in any form. This is a hard no.
Scope · All copy, all formats
Notes · v1.6 hard line 3. “Made in an FDA-registered facility” is the permitted short form — CLM-34, CLM-42.
Never “dermatologist approved”, “dermatologist developed” or “dermatologist formulated”.
Wording · Claim ‘dermatologist-developed’ or imply a dermatologist created the formula. · This is the ONLY approved badge wording — never ‘Dermatologist Approved’, ‘Dermatologist Developed’ or ‘Dermatologist Formulated’.
Scope · All copy; badge wording
Notes · A real customer or creator saying a doctor recommended it to them is their own words and passes — UGC-07.
Never “dermatologist-level results” or anything implying the product delivers what a dermatologist delivers.
Wording · Claim ‘dermatologist-level results’ or any phrasing implying the product delivers what a dermatologist delivers.
Notes · The named live ad “Save 47% OFF + Free Shipping” used this; the repair is “clinic-inspired” — CLM-36.
Never “medical grade”, “professional strength” or “pharmaceutical” attached to the product or serum itself.
Wording · Use ‘medical grade’ for the product or its components. · Attach ‘pharmaceutical’ or ‘pharmaceutical-grade’ to the product or serum itself.
Scope · Product and serum only
Notes · v1.6 states the split explicitly, which resolves AMB-04: “or ‘pharmaceutical-grade’ when describing the facility, cleanroom, water standard, or manufacturing process” is permitted — CLM-34. The replacement for “professional strength” is CLM-36.
Never “clinically proven” or “proven” for the product.
Wording · Claim the product is ‘clinically proven’ or ‘proven’.
Notes · “Proven” is permitted at the ingredient level for PDRN — CLM-39. “Clinically studied compound” is permitted — CLM-33.
Never imply any equivalence to injectable Rejuran or to injectable PDRN procedures.
Wording · Claim any equivalence or similarity to injectable Rejuran or injectable PDRN procedures.
Notes · v1.6 lists it as absolute, in the “Also absolute, unchanged” tail rather than the numbered hard lines.
1.3 Prohibited Scope-of-Condition Claims
Never claim the product treats discoloration, dark spots, PIH, melasma, keloids, or “all scars”.
Wording · Claim the product treats discoloration, dark spots, PIH, keloid scarring, or ‘all scars’. · Severity: hard_block on treatment claims only.
Scope · The CLAIM. Showing discoloured scarring on camera is the intended use, not a violation — VIS-29.
Notes · v1.6 scopes the block to treatment claims only, and B4 adds: “The product is for texture/pitting, not pigment. … PREVENTIVE language tied to scars is allowed.” Preventative wording is CLM-38. The older Derm Micro-Infusion page is a discoloration page and must never appear on screen — VIS-28.
Never imply the product is safe for active acne, open sores, inflamed skin or keloid scarring.
Wording · Imply the product is safe for use on active acne, open sores, or inflamed skin. · Imply the product is safe for keloid scarring.
Never use “#1”, “best” or any product-level superlative in brand copy.
Wording · Superlatives: No product-level superlatives (‘#1’, ‘best’).
Notes · A customer saying “best” is her own words and passes — UGC-05. The only permitted superlative-adjacent claim is that the 90-day guarantee is the longest in the category — CLM-18.
1.4 Prohibited Numeric, Comparative & Comfort Claims
Never “pain-free” or any absolute comfort claim in brand copy or voiceover.
Wording · Write ‘pain-free’ or any absolute comfort claim in the BRAND’s own copy, overlay or voiceover.
Scope · Brand copy and voiceover only
Notes · v1.6 lists it as absolute in the tail. Repairs are “gentle” and “minimal discomfort” — CLM-37. A real person describing their own sensation passes — UGC-09, UGC-13.
Never use “up to 30x more effectively” without the full phrase, or frame it as a results multiplier.
Wording · Claim ‘Up to 30x more effectively’ without the full phrase ‘Up to 30x more effectively than topical application alone’. It must be framed as an absorption multiplier, not a results multiplier.
Notes · v1.6 files this as a GRAY AREA rule, not a hard line. The permitted full-phrase form is CLM-21.
Never claim superiority over any named procedure or brand — “better than laser”, “worked better than my $4,000 laser”.
Wording · Claim superiority over named procedures or brands (‘better than laser’, ‘worked better than my $4,000 laser’).
Never say “works for all skin types” without the fish-allergy caveat.
Wording · Say ‘works for all skin types’ without the allergy caveat.
Notes · The permitted full-phrase form is CLM-22.
1.5 Required Claim Elements & On-Screen Text
State the 90-day money-back guarantee flatly, with zero hedging. Unconditional.
Wording · State the 90-day money-back guarantee with zero hedging as an unconditional business policy. · The 90-day money-back guarantee is the only claim stated flatly with zero hedging.
Scope · Brand copy and voiceover
Notes · The only flat promise in the book, and the only permitted superlative-adjacent claim (“longest in the category”). v1.6 ALWAYS PASS — never a fail either way. Split register: hedge the skin, never hedge the 90 days — BRD-01.
Carry a qualifier on every skin outcome claim.
Wording · Absolutes: Do not use absolutes for skin outcomes. Hedge everything about the skin with qualifiers like ‘helps improve the appearance of’, ‘visibly’, ‘less noticeable’, ‘smoother’. Qualifiers: Required for all skin outcome claims.
Put “Results may vary” on screen on any before/after, any personal result, and any results section — small but legible.
Wording · ‘Results may vary’ must be on-screen during any results section or personal result. This is the one visual rule that never bends.
Scope · Trigger: any ad showing a before/after or referencing a personal result
Notes · v1.6 hard line 5, and B3: “This is the one visual rule that never bends.” “Individual results vary” is an accepted second string — CLM-43. The fix for a missing overlay is the overlay, not the shot.
If the 30x absorption claim appears, use the full phrase: “Up to 30x more effectively than topical application alone”, framed as absorption, not results.
If an all-skin-types claim is made, use the full phrase: “works for all skin types, unless you have a fish allergy”.
Keep “at home” next to any clinic comparison, and next to any price contrast, so it never reads as the clinic treatment for less.
Wording · A price contrast like ‘$79 vs $3,000 clinic series’ must keep ‘at home’ attached near the price line so it doesn’t read as claiming the clinic treatment for $79.
Notes · The v1.6 example uses the product’s own price, which the program ruling bars — CPY-01. The attachment requirement carries over and now also governs any permitted contrast form — CPY-30.
Quote the dermatologist endorsement word for word, punctuation included, and attribute it. Never strengthen it, never paraphrase it upward, never use it to support “dermatologist-developed”.
Wording · Reference the Dr. Elena Dinkollari endorsement, attributed as given and not paraphrased into something stronger.
Notes · Any doctor on camera has to be real — “fake doctor” is a live accusation in the comment threads — VIS-05.
1.6 Conditional Claims & Situational Disclaimers
Whenever the ad — or a comment response — addresses which scar types it treats: name acne scarring, atrophic scarring, ice pick, boxcar and rolling, and put the keloid line on screen — “Keloids are a different type of scar tissue; this product is not formulated or tested for keloid scarring”.
Wording · Trigger: Any ad or comment response addressing what scar types the product treats. Text: “Keloids are a different type of scar tissue; this product is not formulated or tested for keloid scarring.” Must name atrophic, ice pick, boxcar, and rolling scars specifically.
Notes · v1.6 widens the trigger to comment responses, which v1.5 did not mention. B4 severity for keloid overclaim: hard_block.
For a visibly pregnant creator, or any ad discussing pregnancy-related skin changes: “Consult your doctor before use if pregnant or nursing”.
Wording · Trigger: Any ad featuring a visibly pregnant creator or discussing pregnancy-related skin changes.
Notes · v1.6 widens the trigger beyond pregnancy itself to discussion of pregnancy-related skin changes.
Name procedures and legacy products only as your own first-person history: “I did a CO2 laser, it did nothing for me”.
Wording · Reference named medical procedures (CO2 laser, Fraxel) or legacy brands (Bio-Oil, Mederma) only in a first-person ‘I tried it, it didn’t work for me’ context.
When framing value, frame it without the product’s own price: cheaper because it removes clinic overhead, appointments and labour — not because it is lesser.
Wording · Contrast price/value against clinic procedures by framing it as removing clinic overhead, appointments, and labor costs.
Notes · The frame is v1.6’s. The price exclusion is the program ruling — CPY-01. Contrast against a third party’s price is permitted — CPY-30.
If the light, room or conditions differ between a before and an after, say so.
Wording · If the light is clearly different, the creator naming it (‘different room, no filter’) works better than any rule.
A real person’s own hedged estimate of their own result is permitted (“around 60%”, “diminished by 60-70% after six treatments”). A clean product-claim percentage is not.
Wording · PERMITTED (brand 2026-09-22): a real customer’s own HEDGED estimate of their own result — ‘around 60%’, ‘my scars have diminished by 60-70%.’
Notes · The hedge and the fact it is that person’s own estimate are what make it honest. This is the device that defuses the scam gate — BRD-09.
1.7 Product Representation — Claim Side
The product may be described as a sterile, single-use 24K gold microneedle stamp (0.5mm) paired with a 0.3% PDRN regenerative serum.
Wording · State that the stamp is a sterile, single-use 24K gold microneedle stamp (0.5mm). · 24K gold microneedle stamp: 0.5mm, sterile, single-use per head.
Words printed on the box (like “Brightening”) are packaging, not a claim. They may appear in a product shot but do not become a product claim.
Wording · Packaging copy: words printed on the physical box (e.g. ‘Brightening’) are packaging design, not an advertising claim, and are never evaluated as one.
State the pack logic plainly: 1 pack = 2 treatments = 1 month, and the routine is twice a month.
Scope · Routine and cadence framing
“Scar Repair Kit” is the product’s actual name. “Repair” and “Regenerating” in the product or ingredient name are not therapeutic claims.
Wording · Product name: ‘Scar Repair Kit’ is the product’s actual name. ‘Repair’ and ‘Regenerating’ in the product or ingredient name are not therapeutic claims.
Notes · Never flag either word as a claim. The international-regulator rule that treated them as therapeutic was explicitly withdrawn — CLM-46.
Older boxes saying DERM and current boxes saying THE DRM LAB are both real — you can call it “Derm” on camera. The wordmark THEDRMLAB, with the E styled to look like an F, is the real logo, on the vial too.
Wording · Logo: the wordmark reads ‘THEDRMLAB’ with the E styled so it resembles an F. This is the real logo, on the vial too. Never flag it as a typo.
Notes · Things that look wrong and aren’t. Do not “correct” either in post.
1.8 Permitted Claim Library
Approved as written. Nothing here needs a hedge of its own beyond the standing qualifier requirement — CLM-19.
Do not violate Meta Advertising Standards on Personal Health and Appearance by implying negative self-perception.
Wording · Violate Meta Advertising Standards on Personal Health and Appearance by implying negative self-perception (though direct address of insecurity is permitted by the brand).
Scope · All Meta placements
Notes · The first explicit platform-policy rule in either document. The direct-address carve-out is CPY-38 / AUD-15. Second platform rule: visible needles-in-skin, blood or skin trauma “has led to prior Meta rejections” — VIS-15.
“Individual results vary” is an accepted alternative string to “Results may vary”.
Wording · Text: “Results may vary” or “Individual results vary” (on-screen text, small but legible).
Scope · The overlay on any before/after, personal result or results section — CLM-20
Allowed skin-outcome phrasing: “Helps improve the appearance of scar depth and texture” · “skin looks smoother, more even, less pitted over time” · “supports the skin’s own collagen rebuilding process”.
Notes · v1.6 ALWAYS PASS. Still carries a qualifier — CLM-19.
Allowed mechanism statement: creams sit on the epidermis, the barrier blocks them, atrophic scars form in the dermis, and the 0.5mm stamp creates micro-channels to help the serum reach the upper dermis.
Notes · v1.6 ALWAYS PASS — “Mechanism explanations (skin barrier, dermis depth, micro-channels) in ANY script, including a Frustrated Veteran script.” Never a failure. Segment fit is an editor note only — AUD-06.
Allowed ingredient facts: 0.3% PDRN triggers cellular repair and stimulates collagen synthesis and is a clinically studied compound used in Korean dermatology clinics · EGF supports renewal and tissue regeneration · Centella boosts collagen and accelerates recovery · Hyaluronic Acid hydrates and supports the barrier · Panthenol and Niacinamide soothe and strengthen.
Allowed facility facts: “Made in an FDA-registered facility” · “Class 100 sterile cleanroom” · “GMPC” · “ISO 22716” · “pharmaceutical-grade” or “pharmaceutical-grade water standard” when describing the facility, cleanroom, water standard or manufacturing process.
Scope · Facility and process only
Notes · v1.6 also allows the full phrase “Made in an FDA-registered, GMP-certified facility” in ALWAYS PASS, while saying the long form is not required — CLM-42. Pace the credentials — AFD-06.
“Dermatologist Recommended” — the only badge wording. Dr. Elena Dinkollari’s endorsement, quoted exactly as given.
Scope · Badge wording
Notes · v1.6 hard line 9 covers the wording only: “This applies ONLY to the dermatologist badge — every other badge, seal or end-card claim the brand uses, such as the 90-day guarantee badge, is unaffected.” Badge design and placement are free — VIS-33.
Allowed framing phrases: “clinic-inspired” · “the same category of ingredient used in clinics” · “professional-grade technology, made simple enough to use at home” — the required replacement for “professional strength”.
Wording · Use ‘Professional-grade technology, made simple enough to use at home’ instead of ‘professional strength’.
Allowed comfort language: “minimal discomfort”, “gentle”, and a real person’s own sensation in their own words.
Notes · Both review lines are honest: “the discomfort is minimal” and “a bit painful on thinner parts of the face”. Never “pain-free” — CLM-14.
“Helps prevent hyperpigmentation from making your scars appear darker” — preventive, tied to scars.
Wording · PREVENTIVE PIGMENT LANGUAGE: language about preventing scars from darkening is allowed when it is tied to scars — e.g. ‘helps prevent hyperpigmentation from making your scars appear darker’ (the formula contains ingredients that support this).
Notes · v1.6 ALWAYS PASS; B4 confirms the block is “on treatment claims only”. Claiming it treats pigment is not allowed — CLM-11.
“Proven” is permitted at the ingredient level, for PDRN only. “Clinically studied compound” is permitted for PDRN.
Proof figures approved as written: 90 days money-back guarantee · 0.5mm sterile single-use 24K gold microneedle stamp · 4.8★ from 1,465 verified reviews · FDA-registered facility, GMP / GMPC, ISO 22716, Class 100 sterile cleanroom · Dermatologist Recommended · ~2,100 new customers a month, 60% of them subscribing.
Notes · Carried from v1.5 — v1.6 contains no proof-figure list and no review rating at all (verified: no occurrence of “4.8” or “1,465”). Guarantee and review-figure rules: CLM-18, UGC-02.
Name salmon DNA honestly as the source, for credibility — “PDRN is derived from salmon DNA”. Never for shock value, never as a punchline.
Wording · Salmon DNA: Can be named honestly as the source of PDRN for scientific credibility, but never as a gimmick, shock value, or punchline.
Notes · v1.6 B4 names the objection directly: the “fish sperm ick factor”. Severity: caution.
“Made in an FDA-registered, GMP-certified facility” is permitted in full. The short form is also fine — the long form is not required.
Wording · State the product is made in an ‘FDA-registered facility’. The short form is fine on its own — the full ‘FDA-registered, GMP-certified facility’ is not required (brand 2026-09-21; the long form does not fit most designs).
The international-regulator rule treating “repair” and “regenerating” as therapeutic claims does not apply and was withdrawn.
Wording · Removed 2026-09-21 at the brand’s instruction: the international-regulator rule treating ‘repair’ and ‘regenerating’ as therapeutic claims was never agreed and does not apply — ‘Scar Repair Kit’ is the product’s name.
Notes · Recorded so it does not creep back in from an older rules doc.
Namable scar types: acne scarring, atrophic scarring, ice pick, boxcar and rolling.
Wording · Name specific scar types: acne scarring, atrophic scarring, ice pick, boxcar, and rolling scars.
Notes · v1.6 adds “acne scarring” and the full “atrophic scarring” to the v1.5 list. Naming them triggers the keloid disclaimer — CLM-25.
2. Copy/Messaging Rules
Brand voice, the rules that govern copy and voiceover, and the discipline for testimonial and UGC. These rules govern the brand’s mouth — a real person’s own words are held to a different standard, and v1.6 widens that difference considerably.
2.1 Price, Discount & Offer Framing
GOVERNED BY THE PROGRAM RULING, which is stricter than v1.6 on two points and looser on none. v1.6 permits a discount CTA outright and permits the product’s own price inside a contrast frame; the program permits neither, while opening two new permissions. The program governs whether an ad launches; brand QA governs whether it fails review. Both positions are recorded — see CF-01.
Never state the product’s actual price — no pack price, no box price, no plan price, no subscription price.
Wording · PROGRAM RULING — We are not allowed to mention the product’s actual prices in the ads we make for them.
Scope · All copy, on-screen text, end card, CTA
Notes · This supersedes v1.5’s blanket ban and v1.6’s permitted “‘$79 at home vs. a $3,000 clinic series’” example, because $79 is the product’s own price. Sole permitted expression of price is the per-day unit form — CPY-29. Contrast against a third party’s price is permitted — CPY-30.
The ad must not be purely a promo, discount or offer pitch — not built around what the buyer saves, what the offer is, or what the plan costs.
Wording · PROGRAM RULING — Our ads for them are not allowed to be PURELY presenting/focusing on promos, discounts and offers.
Scope · Whole creative, all formats
Notes · v1.6 puts “an ad built ENTIRELY around price” under NEVER ALLOW — Tone, and files it as a B4 guideline, not a hard line. The program ruling generalises the test from price to promos, discounts and offers. Selling the routine is the alternative — CPY-04.
Sell the routine, not a one-time fix. Creative has to sell the habit — something you do twice a month and keep doing, with a real count attached.
Wording · Subscription framing that sells the ROUTINE — something you do twice a month and keep doing, not a one-time fix.
Scope · Every concept
Notes · v1.6 files this as messaging priority 7 — DIRECTION, not a gate. A “one box and done” framing drags people to the smallest plan and undercuts the business.
Through November and December, do not lean on the 6-month offer at all.
Wording · Through November and December, don’t lean on the 6-month offer at all.
Scope · Nov–Dec creative only
Notes · Carried from v1.5. v1.6 never uses the word “offer” — it is silent on plans entirely. Inventory on the 3-month boxes is tight and each 6-month order eats two of them.
You don’t have to sell a specific plan — the page does that. Monthly is fine.
Wording · creators do not need to sell a specific plan (the page does that) and monthly is fine.
Per-day unit pricing is permitted: “start at $X a day”. This is the only permitted expression of the product’s price.
Wording · PROGRAM RULING — We can include stuff such as “start at X dollars a day” etc.
Scope · Per-day unit rate only — never a pack, box or plan figure
Notes · This form appears in neither v1.5 nor v1.6; it exists only in the program ruling. The figure itself is supplied nowhere. See AMB-12. Because a per-day rate is derived from the actual price it is an authorised carve-out, not a clean exception — see CF-08.
Pricing and value contrast against competitors is permitted — clinic series, laser series, professional microneedling, appointment and labour costs.
Wording · PROGRAM RULING — We can include pricing/value contrast against competitors. · Contrast price/value against clinic procedures by framing it as removing clinic overhead, appointments, and labor costs (e.g., ‘$79 at home vs. a $3,000 clinic series’).
Scope · Third-party prices only
Notes · The frame is v1.6’s; the exclusion of our own price is the program ruling. v1.6’s worked example is unusable as written because $79 is our actual price — keep the contrast, drop our side of it. “At home” must stay attached — CLM-23.
2.2 Prohibited Language & Register
Never change a number to look better, or invent a result, a count or a testimonial.
Wording · Results, treatment counts or quotes that are not real — invented numbers, a count changed to look better, fabricated testimonials.
Scope · All copy, all footage
Notes · v1.6 hard line 4. See CPY-32 for the corollary: never suggest raising a count either.
No jargon used as authority.
Wording · Jargon-as-authority word salad (‘Clinically advanced regenerative technology’).
Scope · Brand copy and voiceover only — a real person’s own wording is never judged here, BRD-04
No hype in brand copy: “THIS CHANGES EVERYTHING”, “flawless”, “erased”, round-number results, fast-timeline transformations.
Wording · Hype register (‘THIS CHANGES EVERYTHING’).
Notes · Brand copy only. Hype inside a real person’s own words is explicitly not a failure — UGC-10.
Never use “we’re all in this together” as the brand’s identity. It is Banish’s lane.
Wording · Adopting a brand-level ‘community’ or ‘movement’ identity as the overarching voice (‘we’re all in this together’ as positioning). This is a competitor’s (Banish’s) lane.
Notes · One-to-one solidarity inside a script is a different thing and is fine — BRD-08.
Never relentless upbeat cheerleading, cold dismissive bluntness, or “everything is a scam” cynicism.
Scope · Tone — brand copy only; “do not fail for tone” applies to a creator’s own words, BRD-04
Never dwell in misery without ever explaining the mechanism.
Scope · Narrative structure. Unrestricted emotional framing itself is permitted — CPY-36.
Never founder-narrative creative, and never the lab narrating as a character.
Wording · The lab itself narrating as a character. (A doctor or expert on camera in a lab coat is the brand’s authority-VSL format and is fine.)
Never a female script transplanted onto a male creator.
Wording · Use a male ad that is just a female script read by a man.
Notes · The fix for men is a man on camera with his own words — AUD-10.
Never build another version of “woman discovers PDRN”.
Wording · One more version of “woman discovers PDRN”
Scope · Every submission
Notes · A program-side creative-brief instruction, not a QA gate — v1.6 has no equivalent.
2.3 Brand Voice & Positioning
These rules govern the brand’s copy and voiceover; a real person’s own words are never judged on tone — BRD-04.
Never use humor that makes light of the scars or the audience’s insecurity. Humor has exactly one permitted target: the awkwardness of talking about it.
Wording · Use humor that makes light of the scars or the audience’s insecurity.
Notes · RE-TIERED from preference to prohibition on v1.6’s B2 Cannot list. “Yeah I know, a guy talking about his skin, groundbreaking stuff” passes — AUD-13.
Tone rules govern the brand’s copy and voiceover. A real person’s own words are never judged on tone.
Wording · NEVER ALLOW — Tone (in the BRAND’s own copy and voiceover only; a real person’s words are never judged here)
Notes · v1.6 repeats this four times and adds: “Do not fail for … a creator’s own wording.”
Clear the scam gate first, out loud. It is the gate every other objection passes through.
Wording · Pre-empt viewer skepticism out loud (‘I know this looks like every other before and after you’ve rolled your eyes at...’).
Scope · Every concept, opening line
Example · “I know this looks like every other before and after you’ve rolled your eyes at, so let me show you the actual room.”
Notes · v1.6 lists it as permitted and as a “looks like a violation but is OK” item. B4 rates the scam thread hard_block — the number one reputational risk.
Hedge the skin, never hedge the 90 days. The split-register line is the pattern.
Wording · 🤝 Hedged skin claims, unhedged 90 days
Scope · Every concept
Notes · The most underused proof in the category. A whole concept can be built on it.
Voice: unsentimental, exacting, weary but not cynical, plainspoken, quietly confident.
Wording · Personality: Unsentimental, Exacting, Weary-but-not-cynical, Plainspoken, Quietly confident.
The friend who did their homework — precise about the small things, honest about the slow things, flat about the guarantee.
Salmon DNA is science, not a punchline.
Wording · Salmon DNA is science, not a punchline. Name it for credibility … Never for shock value, never as a gag.
Scope · Ingredient framing — CLM-41
Own the open position: nobody in the field is exacting, precise and unsentimental. Being the one that doesn’t exaggerate is the whole strategy.
One-to-one solidarity inside a script (“you’re not alone in this”) is fine and performs.
Wording · NOT prohibited: in-script moments of one-to-one emotional solidarity or relatability between creator and viewer (‘you’re not alone in this’, shared-experience recognition) — a proven performer that stays fully allowed.
Notes · Not the banned brand-level “community”/“movement” identity — CPY-09.
Lead with the desire Saybel’s own words name: “I want to stop hating how I look in certain lighting.” Side light, the front camera, the bathroom mirror.
Notes · The desire is a normal relationship with their own face, not “flawless”.
When in doubt, this passes. QA on this account is moderate and defaults to pass.
Wording · WHEN IN DOUBT: PASS. (Changed 2026-09-21 at the brand’s instruction.) · Overall stance: moderate · Default when uncertain: PASS.
Notes · “A rule that is not on the HARD LINES list below is guidance for creators, not a gate. Flag only what clearly and specifically breaks a named rule.” Carried from v1.5 and made explicit and dated in v1.6.
2.4 Testimonial & UGC
Reviews used in ads must be real, and quoted as real.
Wording · Reviews in ads must be real ones, quoted as real.
Scope · Every review, every survey line, every comment
A real person describing their own sensation passes (“it did not hurt”, “I can barely feel the needles”, “you might feel a little sting”).
Scope · Comfort content in real-person voice
Notes · Do not put brand comfort language in their mouth — “it did not hurt” is a real person’s sentence, not the brand’s.
A real person’s own words about their own experience are their words and pass — including “miraculous”, “game changer”, “it didn’t hurt”, “nearly gone after 3 treatments”.
Wording · A real customer’s or creator’s own words about their experience are their words, not brand copy. · A creator’s or customer’s own words, including hype (‘miraculous’, ‘game changer’), comfort (‘it didn’t hurt’, ‘barely felt it’).
Notes · v1.6 widens this materially — see UGC-10 through UGC-14.
A customer’s own comparison to clinic treatment may be quoted as hers. Never lift “as good as a laser” into your own copy.
Wording · a customer’s own comparison. Quote it as hers; never lift “as good as a laser” into your own copy
A customer saying “best” is fine. Brand copy never does.
Wording · a customer saying “best” is fine. Brand copy never does
Notes · Pairs with CLM-13.
Saybel’s line is a named, verified testimonial the brand has cleared and may be used as the opener.
Notes · The rest of the sheet is anonymous reviews — quote them, but do not attach a name.
A creator saying their own doctor recommended it is their own words and passes.
Wording · A real customer or creator saying a doctor recommended it to them is their own words and passes.
Notes · Does not license dermatologist-developer or dermatologist-approved wording — CLM-06.
The public rating 4.8 from 1,465 verified reviews is the only review figure you state in an ad.
Wording · The public rating is 4.8 from 1,465 verified reviews, the number on the site; that is the only review figure you state in an ad
Notes · Carried from v1.5. v1.6 contains no review rating at all — verified: no occurrence of “4.8” or “1,465”.
Survey lines and ad-comment lines are real and usable as real quotes.
Wording · FROM THE POST-PURCHASE SURVEYS AND THE AD COMMENTS · ALSO REAL
Hype language inside a real person’s own words is not a failure.
Wording · Hype language, ‘miraculous’, ‘even tone’, ‘game changer’, benefit mentions outside acne scars (e.g. wrinkles), and comfort descriptions inside a genuine testimonial are NOT failures.
A real person saying “even tone” or reporting their own tone is not a failure.
Wording · ‘even tone’ … are NOT failures
Notes · Distinct from CLM-11: the brand may not claim to treat pigment, but a customer describing her own tone is her experience.
Benefit mentions outside acne scars — e.g. wrinkles — inside a real person’s own words are not a failure.
Wording · benefit mentions outside acne scars (e.g. wrinkles) … are NOT failures
Notes · v1.6 exempts real-person voice only. It does not say whether brand copy may claim wrinkles — AMB-16.
Comfort descriptions inside a genuine testimonial are not failures.
Wording · comfort descriptions inside a genuine testimonial are NOT failures
Notes · “It didn’t hurt” and “barely felt it” are both on-brand in a real person’s mouth. The brand’s own copy may still never say “pain-free” — CLM-14.
A real person reporting their own timeline is not a promise and passes.
Wording · NOTE: a real person REPORTING their own timeline (‘nearly gone after 3 treatments’) is not a promise and passes.
Notes · Pairs with CLM-02: the brand may never promise a timeline; a creator may report their own.
2.5 Treatment Count & Honest Timeline
REWRITTEN AGAINST v1.6’s REAL-COUNT RULE. The previous revision of this rulebook stated 6–10 as a required count. That was wrong — the brand abolished any minimum and any proportionality test.
Never suggest raising a count to look more credible. Inventing a number is the violation, not the number itself.
Wording · Never fail a creative for a low count, and never suggest raising a count to look more credible — inventing a number is the violation, not the number itself.
Notes · The corollary of CPY-06, and the reason the earlier “6 to 10” framing was wrong. CLOSES the previous CF-03.
State the creator’s real treatment count — whatever that number is. There is no minimum and no proportionality test.
Wording · REAL-COUNT RULE (brand feedback 2026-09-21, supersedes the earlier proportionality test): there is NO minimum treatment count and no proportionality test. One person sees results at 3-4 treatments, another at 5-6, another with deeper scars at 12. If the person is real and the number stated is their real number, it passes at ANY count.
Scope · Every results narrative
Notes · Any real count passes at any result size. “3 treatments and it’s nearly gone” passes if it is that person’s real experience.
Name the 90-day timeframe rather than implying speed.
Wording · It names the 90-day timeframe instead of implying speed
Notes · “My Acne Scar Progress In 90 Days” names the timeframe and implies nothing faster. Naming the window is not promising a result by it — CLM-02.
A big result at a low count reads as fake to this audience. Say the real number whatever it is — and do not stage it out either.
Wording · A big result at a low count reads as fake to this audience. Say the real number, whatever it is.
Notes · Carried from v1.5, now constrained from both directions by CPY-15 and CPY-32: neither lower nor raise.
Accutane-finish-line creative is first-person only — never medical advice, never “stop your prescription”.
The honest count IS the answer to the true-cost objection. Say it is a routine: twice a month, a real count, and the whole decision sits inside the money-back window.
Wording · The honest count IS the answer.
Scope · True-cost objection
Notes · The objection: “one box is one month, real results take 6 to 10+ treatments”. Done silently at checkout it reads as bait-and-switch. The 6–10 figure here is context — CPY-31 — not a claim about the creator.
Name the near-quit moment out loud — “around treatment 6 I almost quit”.
Wording · The honest “I almost quit” beat isn’t a risk. It is the most believable thing you can say
Notes · A third of the review sheet is people two treatments in, and a few quit around treatment 3. v1.6: “this ruling is about this scenario, not a required script.”
Make precision the personality. Name the scar types and the depth: “0.5mm, not 0.75mm, and here’s exactly why that matters”.
Wording · Precision: Can be framed as a brand personality trait, e.g., ‘0.5mm, not 0.75mm, and here’s why that matters’.
Name any anomaly out loud — “I’ve got a little makeup on today, but you can still see the texture underneath.”
Product information you may use: the typical range is 6 to 10 treatments, and the full protocol for mild-to-moderate scarring is 6 treatments over three months.
Wording · Most people complete 6 to 10 treatments before evaluating their results, and the full protocol for mild-to-moderate scarring is 6 treatments.
Scope · Context for the routine and for objection-handling — not a required count, and never a reason to change your own number.
High counts are explicitly fine: 8, 10, 12+.
Wording · Be honest about difficulty, high treatment counts (8, 10, 12+), slow progress, and near-quitting moments for credibility.
Honest lower-count lines pass as-is: “2 treatments in and my skin already feels smoother”, “after my 3rd treatment my texture looks better”.
Wording · honest lower-count lines (‘2 treatments in and my skin already feels smoother’, ‘after my 3rd treatment my texture looks better’) pass as-is.
Respect the Q4 sequencing: test in October, lock by mid-November, never build in December.
Wording · Tested in October, locked by mid-November, never built in December
Notes · Carried from v1.5. v1.6 has no occurrence of “October” or “December”.
2.6 Hooks, Emotion & Address
Bold hooks are allowed: “fix your acne scars” passes as a hook. “fix” is not “cure” or “erase”.
Wording · Bold hooks are allowed: “fix your acne scars” passes as a hook. “This cures your scars” fails anywhere it appears.
Hook latitude extends to static headlines. The hook’s job is to stop the scroll; the body of the ad carries the honest claim.
Wording · HOOK LATITUDE (brand rule 2026-09-21): hooks and static headlines may be bold and a little exaggerated — the hook’s job is to stop the scroll and the body of the ad carries the honest claim.
Notes · The hard line is a literal product claim: “this product cures / heals / erases / 100% fixes your scars” fails wherever it appears, hook included — CLM-01.
Open on a real customer’s verbatim sentence. It beats copy written to sound like a testimonial.
Pre-empt the skeptic in the first line. It clears the scam gate in one sentence.
Use the proven hooks as the bar, then write your own in the same family. Steal the structure, not the copy.
Unrestricted first-person emotional framing is permitted: “I couldn’t look at myself in the mirror”, “I’ve cried about this”.
Wording · Use unrestricted first-person emotional framing (‘I couldn’t look at myself in the mirror’, ‘I’ve cried about this’).
Notes · Distinct from CPY-11, which bars misery with no mechanism. Emotional framing is fine; unexplained misery is not.
Second-person address of the viewer’s insecurity is permitted: “still hiding your face in photos?”, “you’ve tried everything”.
Wording · Use second-person address of the viewer’s insecurity (‘still hiding your face in photos?’, ‘you’ve tried everything’).
Notes · Carve-out inside the Meta Personal Health & Appearance block — CLM-49.
2.7 Seasonal & Retention Messaging
November: the brand wants retention content alongside acquisition — what treatment 4 to 6 looks like, and why people who quit early never see the result.
December: September subscribers hit their second charge while still inside their 90 days. Nobody has made creative for that moment yet.
Keep going creative for existing customers is wanted: the real count, the near-quit moment and the learning curve as the spine.
Notes · The reviews describe exactly this moment, including the learning curve: head tilted back, press the ampule head so the serum flows.
3. AI Use Rules
AI is not banned outright. It is permitted where it is verifiable — product renders, needle animation — and banned where the buyer can smell it. The operative tests are whether it reads as AI, and whether anything it makes is presented as real.
3.1 AI-Prohibited
No AI generation that reads as AI.
Wording · AI generation that reads as AI.
Scope · Every AI-assisted asset
Notes · A standard, not a tool ban. Applies to everything except the 3D needle animation, which v1.6 clears in three separate places — AI-07.
Never the Higgsfield “Special Offer” template — it repeatedly trips the NSFW filter.
Wording · Use the Higgsfield ‘Special Offer’ template, as it repeatedly trips the NSFW filter.
An AI dermatologist is not allowed — in any form, on camera or voiceover only.
Wording · ai dermatologist is not allowed
Scope · Every format. Synthetic derm avatars, presenters and expert personas are all out.
Notes · Broader than VIS-05, which only covers an expert on camera. Overlapping failure modes: “fake doctor” is already a live accusation in the comment threads (VIS-05), and an unlicensed synthetic persona risks CLM-49. Brand-owner ruling, flatly worded.
Never generate anything relating to results — a before/after, a progress visual, a depiction of the skin improving, or a count-linked outcome.
Wording · The hard line is do not generate anything relating to results.
Scope · All generated imagery and video, cloning included. Bounded permission is AI-11.
Notes · The decisive rule for AI cloning. A generated before/after fabricates a result regardless of whose face it uses — it trips VIS-08 (no filter/retouching, absolute), AI-03 (never fabricate a result), CPY-06 (never invent a result), and v1.6 hard line 4 (“results… that are not real”). CLOSES the previous CF-09.
AI may not be used to fabricate anything presented as real — a number, a count, a result, a quote, a testimonial, a before/after.
Wording · Fabrication is the one thing that never gets latitude
Scope · Every AI-assisted asset
Notes · STRONGLY IMPLIED. The fabrication prohibition is explicit and is v1.6 hard line 4; applying it to AI output is a direct reading of it, not a separately stated rule.
3.2 AI-Conditional — Product Renders
Never an AI-rendered product shot showing 6 to 12 vials. That is the named violation band.
Wording · AI-RENDERED product shots with 6-12 vials
Scope · AI renders only
Notes · v1.6 names the failing range explicitly, which v1.5 did not.
An AI render of the product may show 2 to 3 vials, max.
Wording · AI-RENDERED product shots with 6-12 vials; 2-3 vials maximum in a render, sharp and legible.
Notes · The guidance applies only to AI-rendered shots. A photograph of the real 12-treatment kit showing 12 vials is accurate and passes — PRD-08.
AI renders of the product must be sharp and legible.
Notes · Still no threshold for “sharp and legible” — AMB-03.
AI product renders must show the product accurately at the correct bundle tier, and the gold stamp must look realistic — not sharper or more clinical than it is.
Scope · AI product renders only
3.3 AI-Permitted
3D / illustrative needle animation is always fine, and is how the brand explains the product. v1.6 clears this in three separate places, unconditionally.
Wording · 3D or illustrative animation of needles entering skin is NOT a failure at all — it is how the brand explains the product. · 3D or illustrative needle animation is always fine.
Notes · Needs no needle or blood blur, being animation rather than real footage — the pair with VIS-15. This CLOSES the previous AMB-02: the two rules do not conflict, animation is carved out of AI-01.
3.4 AI-Cloning Real Creators
The brand’s own workflow. It is permitted for scene and b-roll gaps only, and bounded on one side by AI-10 and on the other by AI-01.
Cloning a real creator from the Drive to fill missing b-roll or scene clips is permitted — provided nothing generated relates to results.
Wording · what we usually did and performed pretty good, was to take our creators on drive and clone them if there are missing any specific clips that you want to include on the video
Scope · Clones of real, consenting creators only — never a synthetic person built from scratch, AI-12
Notes · The brand names the use case: a creator has all her application clips and is missing the before/after — that specific gap is now barred by AI-10. Scene and b-roll gaps remain open. Two standing limits regardless: the clone must not read as AI (AI-01), and a likeness needs a consent basis that no source document establishes — see Missing Information and NTQ-01.
The brand does not want AI UGC personas created from scratch. Clone real creators instead.
Wording · ai ugc we don’t want to create them from scratch
Scope · Synthetic personas built with no real person behind them
Notes · Recorded at its literal strength — “don’t want to” is a preference, not a prohibition, and is tiered Preferred rather than Prohibited for that reason. Never appeared in v1.5, v1.6 or the program ruling; brand-owner instruction.
4. Visual Rules
What the camera may show, and what technical QA checks before brand QA ever sees the ad. Two review stages exist and they are easy to conflate: technical QA runs first on safe zones, thumbnails and format; brand QA runs after on claims. v1.6 covers only the second stage — verified: it contains no occurrence of “9:16”, “safe zone”, “thumbnail”, “aspect”, “duration” or “vertical”.
4.1 Talent & Casting Representation
Never show anyone who appears to be a minor.
Scope · Every frame
Notes · v1.6 hard line 10 and a B4 reputation killer.
Never show someone as pathetic or hopeless.
No blurred or pixelated faces.
Notes · The documents do not distinguish anonymisation from low-quality generation — AMB-01.
Cast the people the category ignores. Overwhelmingly single-skin-tone casting should be flagged.
Wording · Overwhelmingly single-skin-tone casting should be flagged.
Scope · Casting — B4 severity: caution, not a gate
Cast darker skin tones — a key market segment and the ones who can’t risk lasers.
Wording · Darker skin tones are underrepresented and a key market segment (Frustrated Veterans who cannot risk lasers).
Any doctor or expert on camera has to be real. A doctor in a lab coat is the brand’s authority-VSL format and is fine.
Wording · Feature a doctor or expert in a lab coat. This is the brand’s authority-VSL format and is not ‘the lab narrating to the viewer’.
Notes · “Fake doctor” is a live accusation in the comment threads. This covers an expert on camera only — a synthetic dermatologist is barred outright by AI-09.
Close-up, harsh-lit, emotionally direct visuals are the account’s established severity level and are not a violation.
Wording · Use close-up, harsh-lit, emotionally direct visuals and copy, as this is the established severity level for the account. · Close-up macro shots of real pitted and textured scarring, including under harsh or side lighting.
4.2 Product Representation — Visual
Show the product accurately at the correct bundle tier. BUY 1 is one package, two treatments.
Wording · Mandatory: Product shown accurately at the correct bundle tier (e.g., BUY 1 is one package/two treatments).
Notes · v1.6 B3 lists this as Mandatory. Applies to AI renders too — AI-06.
The gold stamp must look realistic, not implied to be sharper or more clinical.
Wording · Mandatory: The gold stamp must look realistic, not implied to be sharper or more clinical.
Notes · v1.6 confirms Mandatory but still supplies no threshold — AMB-03. Stakes rose when it became a gate.
A photograph of the real 12-treatment kit showing 12 vials is accurate and passes.
Wording · A photograph of the real 12-treatment kit showing 12 vials is accurate and passes. The 2-3 vial guidance applies only to AI-rendered product shots.
4.3 Before/After & Proof Visuals
No filters or retouching on a before/after. This is absolute.
Wording · Use any filter or retouching on a before/after. This is absolute.
Notes · “There was a video that looked very airbrushed you used. Please be sincere with your clients.” — a paying customer, still watching for the filter.
A same-room, unfiltered before/after where she is wearing makeup in the after passes, provided nothing is fabricated and the overlay is present. Better still, have her name it.
Wording · PASS — A genuine same-room, unfiltered before/after 90 days apart, but she’s wearing makeup in the after because she filmed on a day she was going out.
Notes · v1.6 records this as a correction from an earlier FAIL (brand 2026-09-22): “Nothing is fabricated, filtered or retouched, and the required overlay logic is unchanged — so it passes.”
Aim for the same light, angle, room and clothing — this is what creators are told. Differences are NOT a failure.
Wording · BEFORE/AFTER GUIDELINE (guideline, not a gate) — Aim for the same light, angle, room and clothing. This is what creators are told. · Differences between the two shots are NOT a failure. Real people filming on a phone cannot match conditions, and a too-perfect match reads as photoshopped and costs trust.
Notes · RE-TIERED from Required to Preferred. v1.6 labels the section “(guideline, not a gate)” and says three times that differences are not a failure. Direction inverted: a too-perfect match now reads as photoshopped. If the light is clearly different, naming it beats any rule — CLM-29, CPY-21.
A split screen pairing a talking head with a close-up of the same person’s skin is two moments, not a before/after — do not judge it as one. Different lighting and setting between the panels is expected.
Wording · Show a split screen pairing a talking head with a close-up of the same person’s skin. This is TWO MOMENTS, not a before/after, and must not be judged as one — different lighting and setting between the panels is expected.
Notes · RE-TIERED from Prohibited to Preferred. This guards against a false positive; it is not a ban on the format. v1.6 lists it twice as explicitly fine.
Same room, same light, no filter. That pairing is what clears the scam gate.
Wording · Same room and same light where you can, no filter ever
Harsh light on real texture is fine. Slick ring-lit afters against dim befores are what fuel the scam thread.
Wording · slick ring-lit afters against dim befores
Notes · Persuasive risk, not a QA gate — v1.6 says “Do not fail for … lighting”.
Healed, flat, pitted or discoloured scarring is NOT active and is the intended use.
Wording · Healed, flat, pitted or discoloured scarring is NOT active and is the intended use.
Scope · What may appear on camera
Notes · NEW in v1.6 and it matters: showing discoloured scarring is fine. Only claiming to treat pigment is prohibited — CLM-11. Do not read CLM-11 as barring the visual.
4.4 Application & Safety Depiction
Do not film the stamp on active breakouts, or on inflamed, open or broken skin.
Wording · Show anyone treating active acne, open sores, or inflamed skin on camera. This is a genuine safety risk and a HARD LINE.
Scope · Every application shot
Notes · v1.6 DETECTION INSTRUCTION: “in EVERY shot where the stamp or device touches skin, inspect the skin itself before judging anything else. Look for raised or red papules, whiteheads, pustules, visibly angry or broken patches, and scabbing — anywhere the device passes, not only where the camera focuses. … Treat any visible active lesion under the device as a fail and name the timestamp.”
Blur the needle area and any blood in real footage. Unblurred needles entering skin, visible blood or visible skin trauma is an automatic fail.
Wording · Unblurred needles entering skin, visible blood, or visible skin trauma in real footage. Real procedure footage (microneedling pen, injections) is allowed when the needle area and any blood are blurred.
Notes · Second platform consequence: v1.6 records this as something that “has led to prior Meta rejections”. 3D animation needs no blur — AI-07.
Real procedure footage — microneedling pen, injections — is allowed when the needle area and any blood are blurred.
Wording · Real procedure footage (microneedling pen, injections) is allowed when the needle area and any blood are blurred.
Laser or treatment b-roll with no needles and no blood is fine.
Wording · Laser or treatment b-roll with no needles and no blood is fine.
4.5 Format, Safe Zones & Thumbnails
TECHNICAL QA territory, running before brand QA. None of this appears in v1.6 — verified: no occurrence of “9:16”, “safe zone”, “thumbnail”, “aspect”, “duration” or “vertical”.
Three hooks per concept, and each one is a genuinely different ad.
Wording · Three hooks per concept. Not one, not six: three, and each one built as its own ad.
Scope · Every concept
Notes · Different visual · different environment or setting · a different person where possible · a different text overlay and different music · its own thumbnail. Meta groups near-identical creatives together and treats them as one. Music and thumbnail clauses do not apply to native — AFD-10, AFD-11.
Same footage with a new text overlay is not a variation. Three ads sharing footage, room, face and music are one ad to the algorithm and cannibalise each other.
Wording · Same footage, new text overlay. The one thing everyone does, and it is useless here.
Notes · Why, per the brand owner: Meta groups ads by Entity ID, separately from the Creative ID your upload gets. Two uploads get different Creative IDs, but if the visual composition is too similar they share an Entity ID — and ads sharing one split delivery data instead of each reaching new people. “You think you uploaded 3 ads but actually Meta might only see 1.” Text changes barely move this; changing the visual is way more powerful. Static equivalent: VIS-36, VIS-37. Native: AFD-11.
Attribution discrepancy: v1.5 attributes this to Meta’s Andromeda delivery system; the brand owner attributes it to Entity ID. Two different mechanisms from two sources. Both recorded; neither asserted as correct — see NTQ-02.
Keep all text — overlays, captions, logo, badge, CTA — out of the top 14% and the bottom 20% of a 9:16 frame.
Wording · Technical QA checks the top 14% and the bottom 20% of the frame. Keep every text overlay, caption, logo, badge and CTA out of those two bands.
Scope · 9:16 VIDEO ONLY — not statics, not native
Notes · Two ads in the first test run failed on safe zones alone, so this check precedes brand QA entirely. The SAFE ZONE META template is the guide — VIS-18. Brand-owner ruling: safe zones are irrelevant to native, which runs on Facebook primary text — AFD-10.
One thumbnail per hook. The only exception is when the frame at 0:00 already has the text overlay on it and the visual is captivating.
Wording · Every hook needs its own thumbnail. The only exception: the very first frame at 0:00 already works as one
Scope · 9:16 VIDEO ONLY — not statics, not native
Notes · A black frame, a random frame or a mid-motion blur does not count as the exception — upload a custom thumbnail.
“Results may vary” must be on screen during any results section or personal result. This is the one visual rule that never bends.
Wording · ‘Results may vary’ must be on-screen during any results section or personal result. This is the one visual rule that never bends.
If a concept can only be one person, change everything else.
Wording · A different person where possible. If it can only be you, change everything else.
Use the SAFE ZONE META overlay template. Drop it on the timeline and keep your text inside it.
4.6 Footage, Lighting & Production Style
No stock-photo-feeling environments and no sterile white clinic backdrops.
Wording · Prohibited: Stock-photo-feeling environments or sterile white clinic backdrops.
Notes · CONFLICT CF-04. v1.6 lists this as Prohibited in B3, then lists “stock-feeling backdrops” under “NOT A FAILURE (do not flag)” in the interpretation guide. Contradicted inside one document.
Real humans, phone-camera one-takes over polished production. A real room, a real face, harsh light on real texture.
Wording · Required Format Defaults: Real humans, phone-camera one-takes over polished production.
Fonts: Inter and Kepler are the defaults; anything that fits the format is fine.
Music is format-conditional. No music for yapper / organic talking-head · trending audio for the testimonial-timeline style · slow, emotional music for b-roll transformation.
Wording · Music is FORMAT-CONDITIONAL, not a blanket default … Do not fail an ad for its music choice unless it clearly mismatches the format.
Notes · “Never fail on music alone.” The word “clearly” is doing unstated work — AMB-13.
An ad is failable on music only if the choice clearly mismatches the format.
Wording · Do not fail an ad for its music choice unless it clearly mismatches the format.
Show the actual room. Pre-empt the skeptic, then prove it.
Badge design and placement are free and are never a failure.
Wording · Badge design and placement are free and are never a failure.
Scope · Badge artwork — wording is restricted by CLM-35 / VIS-27; design and placement are not.
Fonts are never a failure on their own. Inter and Kepler are the default, but similar fonts — or a font that suits the format, such as an AI-animation ad with its own style — are acceptable.
Wording · Similar fonts, or a font that suits the format (an AI-animation ad with its own style, for example), are acceptable. FONTS ARE NEVER A FAILURE ON THEIR OWN.
4.7 Statics — Creative Distinctness
Statics have no hooks, no 0:00 frame and no thumbnail, so VIS-19 and VIS-20 cannot reach them. These two rules are the static equivalent, built from the brand owner’s Entity ID explanation.
Never submit a static variation that swaps only the review text or headline. That is not a variation and it will not reach new people.
Wording · if you’re doing a variation on a concept, change the background, the layout, or the whole visual setup, not just the review quote or headline
Scope · Statics
Notes · The static twin of VIS-20. “What actually creates a new Entity ID is changing the visual structure.” Text-only swaps land in the same Entity ID and cannibalise each other.
A static variation must change the visual structure: different background, layout, composition, colour treatment, product position, props or environment, or a different person.
Wording · What actually creates a new Entity ID is changing the visual structure: different background, different layout, different people, different structure, different color treatment, different composition, different props or environment. · Practical takeaway for static submissions: if you’re doing a variation on a concept, change the background, the layout, or the whole visual setup, not just the review quote or headline.
Scope · Any static submitted as a variation of another static
Notes · Directly answers the failure the brand owner spotted: three statics from one editor, same concept, same product shot, same background, only the review text and headline swapped. Holding the copy and moving the composition is the whole point — AFD-11 applies the same principle to native.
4.8 Graphic, Badge & Page Rules
Never a dermatologist badge worded as anything other than “Dermatologist Recommended” — never Approved, Developed or Formulated.
Wording · A DERMATOLOGIST badge worded as anything other than ‘Dermatologist Recommended’ … This applies ONLY to the dermatologist badge — every other badge, seal or end-card claim the brand uses, such as the 90-day guarantee badge, is unaffected.
Scope · Badge wording only
Notes · v1.6 hard line 9. Design and placement are free — VIS-33. If you downloaded assets before 25-09-2026, delete any “DERMATOLOGIST APPROVED” file: nine ads used it.
Never screenshot any landing page other than the acne-scars page (thedrmlab.com/products/pdrn-infusion-system).
Wording · A screenshot of the wrong landing page (must be the acne-scars page). HARD LINE, confirmed by the brand 2026-09-21 on a real creative.
Notes · The older Derm Micro-Infusion page is a discoloration and redness page; a screenshot of it is an automatic fail — and its subject matter is itself a prohibited claim, CLM-11.
5. Competitor Rules
The comparison is always against the category, never against a named brand. Named brands fall into two groups: hard-blocked, and nameable only inside your own first-person history. v1.6 widens the evaluative-language ban from device brands to any named brand.
5.1 Blocked Competitors — Hard Block
Never name Banish, Qure or Pluune, in any context, positive or negative.
Wording · Direct Competitors (Banish, Qure, Pluune): Hard block on naming these brands in any context, positive or negative.
Notes · v1.6 hard line 10. Note the tension with B4’s “Naming a direct competitor negatively at scale” — CF-05.
Never show Banish, Qure, Pluune, or any brand competing specifically in at-home acne scar treatment.
Wording · Blocked names: Banish, Qure, Pluune, and any other brand competing specifically in at-home acne scar treatment. These names cannot appear in any context.
If your real story involves a blocked brand, replace it with a generic term.
Wording · If a creator has a story about a direct competitor, they must use a generic category term like ‘another at-home microneedling system’ or ‘a different scar stamp I bought online’.
Approved generic substitutes: “another at-home microneedling system”, “another at-home system”, “a different scar stamp I bought online”.
5.2 Nameable Only as First-Person History
Never use evaluative or disparaging language about any named brand — “X is a waste of money”.
Wording · Use evaluative or disparaging language about any named brand (‘X is a waste of money’).
Scope · Any named brand — v1.6 broadens this beyond device brands to all of them. NEW in v1.6.
Never tell viewers to stop using prescription retinol or tretinoin.
Wording · Tell viewers to stop using prescription retinol/tretinoin. · Do not tell people to stop using a prescription.
Dr. Pen, SkinPen, Dermapen, Bio-Oil and Mederma can only appear as your own “I tried it, it didn’t work for me”. No evaluative language, no superiority claims.
Wording · Legacy/Adjacent Brands (Bio-Oil, Mederma, Dr. Pen, SkinPen, Dermapen): Can be named only in a neutral-to-negative first-person ‘I tried it, it didn’t work for me’ context. No evaluative language (‘it’s a scam’) or superiority claims.
Retinol and tretinoin may be distinguished on mechanism (“not built to rebuild collagen at dermis depth”) but never argued against and never implied to be useless.
Wording · Retinol/Tretinoin: May be distinguished on mechanism (‘not built to rebuild collagen at dermis depth’) but never argued against as treatments or implied to be useless.
Notes · “Implied to be useless” is new in v1.6 and broader than v1.5’s “never argued against”. B4 severity: hard_block — “Messaging that implies abandoning a prescription treatment is dangerous.” The stop-a-prescription half is CMP-48.
Clinic procedures — CO2 laser, Fraxel, TCA cross, subcision, professional microneedling — are first-person history only, never “better than”.
Wording · Medical Procedures (CO2 laser, Fraxel, TCA cross, subcision, professional microneedling): Can be named in first-person personal history … Direct comparative superiority is prohibited.
5.3 Tone of Category Criticism
No “it’s a scam” claim, and no superiority claims, against any named brand or procedure.
Wording · No evaluative language (‘it’s a scam’) or superiority claims.
Compare against the category, never against a named brand.
Wording · The comparison is always against the category, never against a named brand.
The value frame is that this removes the clinic overhead — not that it beats the clinic.
Wording · The value frame is that this removes the clinic overhead, not that it beats the clinic.
Notes · Pairs with CLM-28 and CPY-30.
Arguing against the mechanism of creams, gels and scar gels is core positioning and fully permitted.
Wording · Arguing against the mechanism of creams, gels, and scar gels is core positioning and fully permitted.
The paradox angle lives in the clinic-procedure lane.
6. Ad Formats Disallowed
The brief always keeps this category. Two authorities govern price and offers and they do not agree. v1.6 (brand QA) permits discount CTAs and permits the product’s own price inside a contrast frame. The program ruling permits neither, while opening two new permissions. The program decides whether an ad launches; brand QA decides whether it fails review. Both positions are recorded — CF-01.
6.1 Disallowed
Offer-led statics do not run in this program. An ad built around a discount does not launch, regardless of how brand QA treats it.
Wording · Offer-driven statics — Well covered, and not for you (program rule) · offer-led ads don’t run in this program at all
Notes · v1.6 has no occurrence of the word “offer”. This is a program-side block carried from v1.5 and unaffected by the v1.6 discount-CTA PASS.
Evergreen only. The ad may not pivot on what the buyer saves, what the offer is, or what the plan costs.
Wording · PROGRAM RULING — not allowed to be PURELY presenting/focusing on promos, discounts and offers · no price, no offers, evergreen only
Notes · REWRITTEN. The previous version read “No price, no plan pricing, no discount, no offer anywhere in the ad”, which v1.6 contradicted. The evergreen principle stands; the blanket ban on price and discount does not. See CPY-01 and CPY-02.
No landing-page screenshot of any page other than the acne-scars page.
Wording · A screenshot of the wrong landing page
No ad with a minor on screen.
Wording · Anyone who appears to be a minor
A discount or offer end card is not itself a program fail — but it may not make the ad offer-led, and it may not state the actual price.
Wording · CTAs and end cards may state a discount or saving (‘shop now & save up to 58% off’). A CTA is how the product is sold and is never a failure on its own. (v1.6) · Our ads for them are not allowed to be PURELY presenting/focusing on promos, discounts and offers (program ruling)
Notes · RESOLVED as to the price ban — CPY-01. What remains unstated is whether a discount CTA is desirable in this program or merely not fatal — AMB-14. v1.6 passes the “shop now & save up to 58% off” end card explicitly (brand feedback 2026-09-21).
6.2 Permitted-Format Reference
Formats that are permitted, with the lane strength the brief assigns. A short bar is your opening; a full bar is not.
For native primary text ads, submit completely different images.
Wording · just submit completely different images
Scope · Every native submission, and every native variation
Notes · The operational rule for native. Same Entity ID logic as VIS-36 and VIS-20, applied to the native image. Held constant across a native set: the Facebook primary text. Moved per submission: the image, and it must be completely different — not a text swap.
Behind-the-scenes facility / how it’s made: some exists, and it is usually credential-stacked. Pace the credentials and say what each one controls for.
Wording · PASS — Behind-the-scenes facility ad … Every claim is individually true and none is on the hard-line list, so it passes (brand 2026-09-22, correcting the earlier FAIL).
Notes · v1.6 records this as a correction from an earlier FAIL and reclassifies the cumulative impression as “a GUIDELINE, not a gate”. Only an explicit “FDA approved” fails it — CLM-05. Facility wording — CLM-34, CLM-42.
UGC and real-human testimonial video — the dominant winning format, and the fastest lane.
Talking head with mechanism (“the friend who did their homework”) — well covered.
B-roll transformation is permitted and takes slow, emotional music.
Native ad format is allowed. It runs on Facebook primary text, so the video-specific rules do not apply: no safe zones, no thumbnail, no music.
Wording · native ad format is allowed · Native format is text only so safe zones are irrelevant.
Scope · Native placements
Notes · Brand-owner ruling. Exempts VIS-16 (safe zones), VIS-17 (thumbnail) and VIS-25 (music). It does not exempt the ad from any claim, copy or evidence rule — the Facebook primary text is ordinary ad copy, so CPY-01, CPY-02, CPY-29, CPY-30, CLM-18, CLM-19 and the VIS-08 / CLM-20 overlay rules all still govern it. Recorded as a format exemption, not a rules exemption.
7. Audience & Targeting Rules
The audience is defined by exhaustion, not by scarring. Every allocation rule here is a creative rule, and — per v1.6 — segment choice is a brief-level choice, not a QA gate. Aiming at a dropped segment gets an editor note, never a failure.
7.1 Segment Priority & Allocation
Early Discoverers and parents of sons are no longer target segments.
Wording · Early Discoverers and parents of sons are no longer target segments. · a creative aimed at a dropped segment gets an editor note, never a failure
Scope · Concept portfolio and audience research
Notes · NEW in v1.6 and absent from this rulebook’s previous revision, because v1.5 never mentioned those segments at all.
Frustrated Veterans are the main audience — people who already did lasers, subcision or professional microneedling and got little or nothing. Most concepts.
Wording · Frustrated Veterans are now the program’s MAIN audience (people who already did lasers, subcision or professional microneedling and got little or nothing) and get the paradox angle.
Notes · v1.6 restates this as a segment-focus change dated 2026-09-30.
Around 30 to 35% of concepts go to Aware Skeptics — researched the clinic route and never booked it.
Wording · Aware Skeptics get roughly 30-35% of concepts and may use the surface-vs-dermis mechanism lightly.
Men fit inside both remaining segments. Bring net-new concepts for those people before you make another version of “woman discovers PDRN”.
Wording · Men fit inside both remaining segments. … Bring net-new concepts for those people before you make another version of “woman discovers PDRN”.
Notes · Men are 40% of the audience and close to 0% of the creative. “He is not a separate segment.”
Write to one person per ad, and write to the exhaustion rather than the scarring.
Wording · The defining trait isn’t the scarring, it’s the exhaustion. Write to that, and write to one person per ad.
Which segment a creative targets is a brief-level choice, not a QA failure. A creative aimed at a dropped segment gets an editor note.
Wording · Which segment a creative targets is a brief-level choice, not a QA gate: a creative aimed at a dropped segment gets an editor note, never a failure.
Reference mix: 60% women / 40% men; ages 35–45 first, 25–34 second, 50+ third. Segments: Frustrated Veteran 28–45 · Aware Skeptic 25–38.
Scope · Planning and casting
7.2 Mechanism Selection by Segment
Surface vs the dermis is a light touch for Aware Skeptics only — the proof and the guarantee do the heavy lifting.
Wording · Surface-vs-dermis education is a light touch for Aware Skeptics only.
Notes · Segment fit, not compliance. “Do NOT fail the creative for it.”
Frustrated Veteran scripts should take the paradox angle: “the aggressive stuff was supposed to work best and didn’t, nobody knows why, every skin responds differently”.
Wording · Mechanism — the PARADOX angle for Frustrated Veterans, the main audience. … A mismatch is an EDITOR NOTE, never a failure (brand 2026-09-22).
Notes · RE-TIERED from Conditional to Preferred. Surface-vs-dermis in a Veteran script PASSES — v1.6 ALWAYS PASS: “Mechanism explanations … in ANY script, including a Frustrated Veteran script.” Raise the mismatch as an editor note recommending the swap. This CLOSES the previous CF-02.
Choosing the wrong mechanism will not fail QA — it will lose the viewer.
Wording · Getting this wrong won’t fail QA. It will lose the viewer.
Notes · Confirmed by v1.6 in five places, each time paired with “do not fail the creative for it”.
Cast darker skin tones in the paradox angle — the laser risk is their real reason.
7.3 Male Creative
Men are not a separate segment. A guy who did the lasers is a Frustrated Veteran; a guy who doubts all of it is an Aware Skeptic.
A woman’s script read by a man does not pass.
Wording · Use a male ad that is just a female script read by a man.
Mocking the insecurity does not pass. “Yeah I’ve got some craters, no big deal” would fail.
A man’s angle may include a closer shave, because the razor stops catching in the ice pick scars.
The fix for men is creative, not copy: a man on camera, understated, matter-of-fact, talking about his own skin the way he’d tell one friend.
Wording · Feature male creators in an understated, private, matter-of-fact register (‘I don’t really talk about this, but...’).
Notes · v1.6 B4: framing male skin insecurity is a caution, “Requires a quiet, private, understated, matter-of-fact register. Getting it wrong reads as mocking or inauthentic.”
The male register is quiet, private, understated, matter-of-fact: “I don’t really talk about this, but…”
The joke may target the awkwardness of talking, not the scars: “Yeah I know, a guy talking about his skin, groundbreaking stuff” passes.
Wording · PASS — Male creator, understated and matter-of-fact … “Yeah I’ve got some craters, no big deal” would fail.
Notes · “The joke targets the social taboo of the conversation happening at all, not the scars or the insecurity.”
Direct address of the insecurity is allowed: “still hiding your face in photos?” “If you’re still hiding your face in photos, you’re not alone in this. I was too.”
Wording · Second-person address of the viewer’s insecurity (‘still hiding your face in photos?’, ‘you’ve tried everything’).
Notes · Carve-out inside the Meta Personal Health & Appearance block — CLM-49.
The male desire: handle this without making it a whole thing. Private, no drama, no “journey”.
7.4 Triggers & Desires
Open on a trigger scene: the photo they didn’t expect in side lighting · the Accutane finish line · the procedure that did nothing · the quote they couldn’t afford · the drugstore dead end · a deadline · a man sees himself in an ad.
Write to one of the six desires under the purchase: stop hating how I look in certain lighting · someone be straight with me for once · feel smart for choosing this, not desperate · something that reaches the actual problem · safe for my skin · handle this without making it a whole thing.
What every segment shares: daily self-consciousness, avoiding the front camera, certain lighting, years of failed solutions. Cold budget goes to the two segments who have already spent money on this problem and are done waiting for cheap things to work.
High-Friction Checklist
AI cloning & statics
The 11 hard lines (v1.6 §1b)
Also absolute (v1.6 tail)
Program rules (outside brand QA)
Count discipline
Copy & voice
Technical QA (runs first)
AI
Audience
Ambiguities
AMB-12 — The per-day figure itself is supplied nowhere NEW
Rules · CPY-29
PROGRAM RULING — We can include stuff such as “start at X dollars a day” etc.
The ruling authorises the form and leaves X as a placeholder. Neither v1.5 nor v1.6 contains any per-day figure, and no pack, box or plan price appears in any document. Nothing here has been filled in with an assumed number.
AMB-13 — “Start at” anchors to the lowest tier — is naming that anchor permitted? NEW
Rules · CPY-29 / PRD-06
“start at X dollars a day”
“Start at” denotes the cheapest tier. If tiers differ, a per-day rate derived from the smallest tier effectively communicates the entry price. v1.6 makes bundle-tier accuracy Mandatory (PRD-06) but does not say whether the entry tier may be surfaced as a unit rate.
AMB-14 — Are derived totals permitted, or only per-day units? NEW
Rules · CPY-01 / CPY-29
not allowed to mention the product’s actual prices · “start at X dollars a day” etc.
The ruling authorises one expression of price and bars another. It does not address forms in between — “less than a coffee a day”, “two treatments for $X”, or a per-treatment rate. The word “etc.” leaves the boundary open.
AMB-15 — Is a discount CTA desirable in this program, or merely not fatal? NEW
Rules · AFD-05
not allowed to be PURELY presenting/focusing on promos, discounts and offers · CTAs and end cards may state a discount or saving … is never a failure on its own.
v1.6 passes discount CTAs enthusiastically. The program ruling only blocks them as the ad’s focus and says nothing about whether including one is a good idea. Silence is not permission and is not prohibition.
AMB-16 — Wrinkles and other out-of-scope benefits in brand copy NEW
Rules · UGC-12
benefit mentions outside acne scars (e.g. wrinkles) … are NOT failures
v1.6 exempts real-person voice only, and says nothing about brand copy. v1.5 neither permitted nor prohibited wrinkles. Unresolved for brand copy.
AMB-01 — Blurred and pixelated faces OPEN
Rules · VIS-06
Blurred or pixelated faces.
Still no distinction between deliberate anonymisation and low-quality generation. v1.6 restates the prohibition without a carve-out for either.
AMB-03 — No thresholds for “sharp”, “legible”, “realistic” PARTIAL
Rules · AI-05 / PRD-07
2-3 vials maximum in a render, sharp and legible · The gold stamp must look realistic, not implied to be sharper or more clinical.
Partly advanced: v1.6 confirms bundle tier and stamp realism are Mandatory, so they are gates. Still no reference render, no spec, no accepted example. The stakes rose; the threshold is still missing.
AMB-05 — Age floor for the audience OPEN
Rules · AUD-05
Three quarters of buyers are over 30; these are scars carried for years or decades, not teen acne.
Audience description, not a rule. v1.6 bars showing a minor but states no minimum targeting age. No age exclusion appears anywhere.
AMB-06 — Scope of the Nov–Dec 6-month restriction OPEN
Rules · CPY-03
Through November and December, don’t lean on the 6-month offer at all.
Unclear whether this governs ad copy only or also landing-page content the ad points to. v1.6 never uses the word “offer” and does not resolve it. It matters because the page sells the plan.
AMB-07 — Static technical specs — ratio and safe zone PARTIAL
Rules · VIS-16 / VIS-36 / AFD-07
The SAFE ZONE META folder … the 9:16 overlay template. Use it on every video.
Partly closed. The brand owner has now settled native (AFD-10 — no safe zones) and supplied the static creative rule (VIS-36 — change visual structure). Still unstated: the static aspect ratio and any safe-zone band that applies to statics, and pixel values for the 14% / 20% bands. See NTQ-03.
AMB-09 — Male concept quota PARTIAL
Rules · AUD-03
Men are wanted in both … Bring net-new concepts for those people before you make another version of “woman discovers PDRN”.
Partly resolved: v1.6 confirms segment choice is a brief-level call, not a gate. But no minimum share of male-led concepts is stated, so “net-new concepts for those people” still cannot be checked against a number.
AMB-10 — The guarantee inside retention creative OPEN
Rules · CLM-18 / CPY-39
The 90-day money-back guarantee … unconditional · September subscribers hit their second charge while still inside their 90 days.
The brand asks for creative about a subscriber’s second charge inside the guarantee window but does not say whether that ad may restate the guarantee, or whether referencing the window implies a result timeline (CLM-02).
AMB-17 — v1.6 source document is corrupted in one place NEW
Rules · CLM-07
Claim ‘dermatologist-level results’ or any p[page header injected]hrasing implying the product delivers what a dermatologist delivers.
A page header was injected mid-word in the delivered file, splitting “phrasing”. The reading above is the obvious recovery. The H1 also carries mismatched delimiters. Worth re-requesting a clean source before treating v1.6 as canonical.
Need to Ask
NTQ-01 — Is a cloned application clip permitted? Brand owners
Rules · AI-10 / AI-11
What the sources say · AI may not generate anything relating to results — a before/after, a progress visual, a depiction of the skin improving, or a count-linked outcome. “Results” was drawn around results, not around every clip of the treatment itself.
The question · May a real creator be cloned to produce the application act itself — footage of the stamp being used — when that clip is genuinely missing? It is the treatment, not the outcome.
Why it matters · Determines whether AI-11’s permitted scope stops at lifestyle b-roll or extends to re-shooting the treatment act. Note the safety rules still apply to any generated application footage: VIS-14 (never on active breakouts) and VIS-15 (needle and blood blur).
NTQ-02 — Andromeda or Entity ID — which mechanism is authoritative? Brand owners
Rules · VIS-20 / VIS-36 / AFD-11
What the sources say · v1.5 attributes creative clustering to Meta’s “Andromeda delivery system”. The brand owner attributes it to Meta’s “Entity ID”, distinct from the Creative ID an upload receives.
The question · Which mechanism should the rulebook name? Both descriptions produce identical operating advice, so this is a labelling question rather than a behavioural one.
Why it matters · The rulebook currently records both attributions side by side and asserts neither. Picking one keeps future updates from reintroducing the other.
NTQ-03 — Static technical specs — ratio and safe zone Brand owners
Rules · AMB-07 / VIS-36
What the sources say · Safe zones, the 0:00 frame and thumbnails are all specified for 9:16 video only. The static creative rule is now set (change visual structure), but no static ratio or band is stated.
The question · What aspect ratio do statics submit at, and does any safe-zone band apply to them?
Why it matters · Without it, a static creator is working from percentages that were written for video and may not fit their canvas.
NTQ-04 — Is a discount CTA desirable, or merely not fatal? Program
Rules · AFD-05 / AMB-15
What the sources say · v1.6 passes discount CTAs enthusiastically. The program ruling blocks them only as the ad’s focus and is silent on whether including one is a good idea.
The question · Should creators include a discount CTA where it is natural, or avoid it entirely?
Why it matters · Currently we know a discount-led ad will not launch, but not whether a discount CTA inside a routine-focused ad is wanted. Routed to the program rather than the brand owners.
Conflicts
CF-01 — Price, discounts and offer framing — three authorities, now reconciled by the program ruling RESOLVED
Rules · CPY-01 / CPY-02 / CPY-29 / CPY-30 / AFD-01 / AFD-02 / AFD-05
Side A · v1.5, program side: no price, no discount, no offer anywhere; evergreen only; offer-led ads do not run.
Price, plan pricing, discounts or offers (program rule, even though the brand allows discount CTAs in its own ads) · no price, no offers, evergreen only
Side B · v1.6, brand QA side: discount CTAs and end cards never a failure; the product’s own price permitted in a contrast frame.
CTAs and end cards may state a discount or saving (‘shop now & save up to 58% off’). A CTA is how the product is sold and is never a failure on its own. · Contrast price/value against clinic procedures … (e.g., ‘$79 at home vs. a $3,000 clinic series’).
Tie-breaker · PROGRAM RULING: no purely promo/discount/offer-focused ad; no actual product price; competitor price/value contrast permitted; per-day unit pricing permitted.
Our ads for them are not allowed to be PURELY presenting/focusing on promos, discounts and offers · We are not allowed to mention the product’s actual prices · We can include pricing/value contrast against competitors · We can include stuff such as “start at X dollars a day” etc.
What this means · RESOLVED, and it resolves against v1.6 on two points. v1.6’s worked example is now unusable as written because $79 is the product’s actual price — keep the contrast, drop our side of it. The “offer-led” block survives because it is a program rule, not a QA gate; v1.6 never uses the word “offer”. Residual questions are tracked separately as AMB-12, AMB-13, AMB-14 and AMB-15.
CF-02 — Surface-vs-dermis in a Frustrated Veteran script RESOLVED
Rules · AUD-06 / AUD-07 / AUD-08 / CLM-32
Side A · The brand passes it in QA.
PASS — A Frustrated Veteran opens with “two rounds of CO2 and a subcision”, then explains “creams sit on the surface and this reaches the dermis”.
Side B · It is the wrong mechanism for that audience.
It’s the wrong mechanism for someone who has already been deeper than 0.5mm in a clinic. Swap in the paradox angle and the ad gets stronger.
Tie-breaker · v1.6 settles it, in five places.
Do NOT fail the creative for it. Flag it as a note so the editor can swap the line. · Mechanism explanations … in ANY script, including a Frustrated Veteran script. · A mismatch is an EDITOR NOTE, never a failure.
What this means · RESOLVED. Passing QA and working well were never the same thing; v1.6 separates them explicitly. Surface-vs-dermis in a Veteran script passes. The paradox angle is craft direction, and the mismatch is an editor note. AUD-06 re-tiered to Preferred accordingly.
CF-03 — Quoting a low count with a large result RESOLVED
Rules · CPY-06 / CPY-15 / CPY-32 / CPY-35 / UGC-03
Side A · A real person’s own words pass, including “nearly gone after 3 treatments”.
‘the results have been miraculous’, ‘it didn’t hurt’, ‘nearly gone after 3 treatments’ all pass because they’re real and reported, not promised.
Side B · A big result at a low count is what this audience reads as fake.
A big result at a low count reads as fake to this audience. Say the real number, whatever it is. · Round numbers, fast timelines and slick ring-lit afters are what fuel the scam thread.
Tie-breaker · v1.6 abolishes any minimum and forbids correcting upward.
there is NO minimum treatment count and no proportionality test … it passes at ANY count. Never fail a creative for a low count, and never suggest raising a count to look more credible — inventing a number is the violation, not the number itself.
What this means · RESOLVED. The honest number is published as-is; it may be neither lowered to look modest nor raised to look credible. CPY-15 and CPY-32 now constrain it from both directions. Note this means the previous revision’s “6 to 10 treatments” as a required count was wrong — that figure is now CPY-31, product information only.
CF-04 — Stock-photo backdrops — v1.6 contradicts itself REQUIRES RESOLUTION
Rules · VIS-24
Side A · Prohibited.
B3 · VISUAL REQUIREMENTS · Prohibited: Stock-photo-feeling environments or sterile white clinic backdrops.
Side B · Not a failure.
§4 B3 INTERPRETATION · NEVER ALLOW — Visuals … NOT A FAILURE (do not flag): fonts, music, lighting differences between before/after shots, stock-feeling backdrops, a real 12-vial kit photo, discount CTAs, or production value.
What this means · OPEN. The same document prohibits it in one section and tells reviewers not to flag it in another. v1.6’s own hierarchy would favour the later “do not flag”, but it also states that HARD LINES are the only automatic fails, and stock backdrops are not on that list. Not resolved here.
CF-05 — Competitor naming — hard block versus “negatively at scale” REQUIRES RESOLUTION
Rules · CMP-01 / CMP-02
Side A · Absolute block, any context.
Hard block on naming these brands in any context, positive or negative. · §1b hard line 10: Naming Banish, Qure or Pluune.
Side B · The reputation killer is about scale and negativity.
B4 · REPUTATION KILLERS: Naming a direct competitor negatively at scale.
What this means · OPEN. A hard block admits no “at scale” carve-out, so the two statements cannot both be literally true. Practically: naming them at all fails hard line 10, so the carve-out cannot be relied on. Recorded rather than resolved.
CF-06 — “These and only these are automatic fails” versus the longer prohibition lists REQUIRES RESOLUTION
Rules · CLM-01 / CLM-03 / CLM-06 / CLM-07 / CLM-09 / CLM-13 / CMP-47
Side A · The hard lines are exhaustive.
§1b HARD LINES (absolute — these and only these are automatic fails)
Side B · Roughly twenty further items are prohibited outside that list.
B1/B2 Cannot and ALWAYS FAIL lists include ‘clinically proven’, ‘dermatologist-level results’, product-level superlatives, ‘Removes’, ‘permanent results’, ‘melasma’, evaluative language about a named brand.
What this means · OPEN, but low practical impact: the extra items are prohibited even if they are not auto-fail. This rulebook records them as CANNOT rather than HARD for exactly that reason.
CF-09 — Cloning a creator to make a missing before/after — resolved against it RESOLVED
Rules · AI-03 / AI-10 / AI-11 / VIS-08 / CPY-06
Side A · The brand owner’s worked example, stated as normal practice.
for a creator you have all the clips of her doing the application and it’s missing the before-after clips, you can clone the creator and create those missing clips
Side B · v1.6 hard line 4, and four hard-line rules in this book.
Results, treatment counts or quotes that are not real — invented numbers, a count changed to look better, fabricated testimonials. · Never generate anything relating to results.
Tie-breaker · The owner then drew the boundary themselves, in the same ruling round.
The point here is generating B-Rolls to fill script gaps. The hard line is do not generate anything relating to results.
What this means · RESOLVED against the example. Cloning is permitted for scene and b-roll gaps — AI-11 — and barred for anything relating to results — AI-10, now a hard line. A generated before/after fabricates a result regardless of whose face it wears, so it trips VIS-08, AI-03, CPY-06 and v1.6 hard line 4. The rulebook keeps CLM-20’s overlay requirement unchanged. One residual question is parked as NTQ-01: whether a cloned application clip is in scope.
CF-10 — Does the native format vary by text or by image? RESOLVED
Rules · AFD-10 / AFD-11 / VIS-36 / VIS-20
Side A · One ruling said native is text only, which would leave text as the sole variable.
Native format is text only so safe zones are irrelevant.
Side B · The next said to submit completely different images for the same native copy.
For native primary text ads, submit completely different images. The copy is Facebook primary text.
Tie-breaker · The owner settled it by giving the operating instruction rather than resolving the format’s anatomy.
It’s just: for native primary text ads, submit completely different images.
What this means · RESOLVED operationally, and deliberately recorded without any claim about whether native carries an image. An earlier draft of this rulebook asserted that native was exempt from the visual-variation requirement; that was wrong and would have let any native image pass. Native is exempt from the video mechanics — safe zones, thumbnail, music (AFD-10) — and not exempt from visual variation: the image must be completely different while the primary text is held constant (AFD-11). The Facebook primary text still carries every copy, claim and price rule.
CF-07 — ‘Removes’, ‘gone’ and ‘permanent’ are in the fail lists but not the hard-line pattern list REQUIRES RESOLUTION
Rules · CLM-01
Side A · Prohibited and ALWAYS FAIL.
B1 Cannot: ‘removes scars’ … or that results are ‘gone’ or ‘permanent’. · §2 ALWAYS FAIL: “Removes”, “erases”, “cures”, “permanent results”.
Side B · The hard-line pattern omits them.
§1b hard line 1: Literal product claims: ‘cures’, ‘heals’, ‘erases’, ‘100% fixes’ your scars.
What this means · OPEN. Almost certainly a drafting omission — v1.5 also banned all seven words, and this rulebook keeps all seven prohibited. ‘Gone’ appears in no v1.6 fail list at all, though the on-brand example contains “It’s not gone.” Treat all seven as prohibited; the pattern list is narrower than the intent.
CF-08 — Per-day unit pricing versus the ban on the actual price REQUIRES RESOLUTION
Rules · CPY-01 / CPY-29
Side A · The actual price may not be mentioned.
PROGRAM RULING — We are not allowed to mention the product’s actual prices in the ads we make for them.
Side B · A per-day rate is permitted.
PROGRAM RULING — We can include stuff such as “start at X dollars a day” etc.
What this means · OPEN by construction — the ruling creates the tension it then authorises. A per-day rate is arithmetic derived from the actual price, so “actual price” now has two expressions: one barred and one allowed. The boundary between them is not drawn. Tracked as AMB-12, AMB-13 and AMB-14. This rulebook does not invent a boundary.
Missing Information
- The per-day unit figure, and the tier “start at” anchors to — no number appears in any of the three sources (AMB-12, AMB-13).
- Whether derived totals — per-treatment rate, “two treatments for $X”, “less than a coffee a day” — are permitted, or only per-day units (AMB-14).
- Whether a discount CTA is wanted in this program or merely not fatal (AMB-15, NTQ-04).
- Whether brand copy may mention benefits outside acne scars, such as wrinkles; v1.6 exempts real-person voice only (AMB-16).
- A clean copy of v1.6 — the delivered file has a page header injected mid-word in B1, splitting “phrasing” (AMB-17).
- The consent and likeness basis for cloning a real creator (AI-11). No source document establishes that Drive footage carries consent for a digital clone, nor who grants it. Nobody should clone a creator without this.
- Pixel values for the top 14% and bottom 20% safe-zone bands — only percentages are given.
- Static aspect ratio and any safe-zone band for statics; native is settled (AFD-10) but statics are not (AMB-07, NTQ-03).
- Duration specs for statics and native; none of the three sources gives one.
- The acceptance test for “three genuinely different ads” — the criterion is descriptive, with no measurable threshold.
- A reference render or asset defining “sharp and legible” for AI product shots (AMB-03).
- A minimum share or count of male-led concepts required per submission (AMB-09).
- A minimum age for targeting; “not teen acne” is audience description, not an exclusion (AMB-05).
- Whether the six-treatment protocol applies identically across scar types — ice pick is named most often but no per-type protocol is given.
- Full ingredient list beyond the named actives, and the concentration of anything other than PDRN.
- The evidence behind “up to 30x more effectively than topical application alone”, and whether it applies to the serum or the system.
- Music licensing, and whether trending audio is cleared for paid ad use.
- Compensation or relationship disclosure for testimonial creators and for Saybel.
- Geography: target country or region is not stated in any of the three sources.
- Approval workflow beyond the QA gates — who signs off, and in what order across technical and brand QA.
- What happens on a technical QA fail: resubmission, revision, or kill.
- A formal legal review of any kind. v1.6 states plainly: “All compliance boundaries are founder judgment, not formal legal review.”